Diclofenac Sodium is Used for treating or controlling ocular inflammation in the affected eye. It was first introduced by Novartis Pharmaceuticals Corp in its drug Voltaren on Jul 28, 1988. Other drugs containing Diclofenac Sodium are Solaraze, Voltaren Arthritis Pain, Dyloject, Pennsaid, Diclofenac Sodium, Voltaren-Xr. 48 different companies have introduced drugs containing Diclofenac Sodium.

Diclofenac Sodium Patents

Given below is the list of patents protecting Diclofenac Sodium, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Pennsaid	US8546450	Treatment of pain with topical diclofenac compounds	Aug 09, 2030	Horizon
Pennsaid	US8546450	Treatment of pain with topical diclofenac compounds	Aug 09, 2030	Nuvo Pharms Inc
Pennsaid	US8217078	Treatment of pain with topical diclofenac	Jul 10, 2029	Horizon
Pennsaid	US8217078	Treatment of pain with topical diclofenac	Jul 10, 2029	Nuvo Pharms Inc
Pennsaid	US8618164	Treatment of pain with topical diclofenac compounds	Jul 10, 2029	Horizon
Pennsaid	US8618164	Treatment of pain with topical diclofenac compounds	Jul 10, 2029	Nuvo Pharms Inc
Pennsaid	US8741956	Treatment of pain with topical diclofenac	Jul 10, 2029	Horizon
Pennsaid	US8741956	Treatment of pain with topical diclofenac	Jul 10, 2029	Nuvo Pharms Inc
Pennsaid	US9370501	Treatment of pain with topical diclofenac	Jul 10, 2029	Horizon
Pennsaid	US9375412	Treatment of pain with topical diclofenac	Jul 10, 2029	Horizon
Pennsaid	US9415029	Treatment of pain with topical diclofenac	Jul 10, 2029	Horizon
Pennsaid	US8252838	Diclofenac topical formulation	Apr 21, 2028	Horizon
Pennsaid	US8563613	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US8871809	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US9066913	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US9101591	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US9132110	Treatment of pain with topical diclofenac	Oct 17, 2027	Horizon
Pennsaid	US9168304	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US9168305	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US9220784	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US9339551	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US9339552	Diclofenac topical formulation	Oct 17, 2027	Horizon
Pennsaid	US9539335	Diclofenac topical formulation	Oct 17, 2027	Horizon
Dyloject	US8946292	Formulations of low dose diclofenac and beta-cyclodextrin	Mar 22, 2027	Javelin Pharms Inc
Dyloject	US6407079	Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation	Jun 18, 2019 (Expired)	Javelin Pharms Inc
Solaraze	US5792753	Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs	Aug 11, 2015 (Expired)	Fougera Pharms
Solaraze	US5914322	Treatment of disease and conditions	Aug 11, 2015 (Expired)	Fougera Pharms
Solaraze	US5985850	Compositions comprising hyaluronic acid and drugs	Aug 11, 2015 (Expired)	Fougera Pharms
Diclofenac Sodium	US5603929	Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds	Nov 16, 2014 (Expired)	Falcon Pharms
Diclofenac Sodium	US5653972	Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds	Nov 16, 2014 (Expired)	Falcon Pharms
Solaraze	US5639738	Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs	Jun 17, 2014 (Expired)	Fougera Pharms
Solaraze	US5852002	Treatment of conditions and disease	Jun 17, 2014 (Expired)	Fougera Pharms
Solaraze	US5929048	Treatment of conditions and disease	Jun 17, 2014 (Expired)	Fougera Pharms

Add above patents to watchlist

Diclofenac Sodium's Family Patents

Full family tree

Diclofenac Sodium Generic API Manufacturers

Several generic applications have been filed for Diclofenac Sodium. The first generic version for Diclofenac Sodium was by Roxane Laboratories Inc and was approved on Jun 29, 1995. And the latest generic version is by Encube Ethicals Private Ltd and was approved on Apr 9, 2025.

Given below is the list of companies who have filed for Diclofenac Sodium generic, along with the locations of their manufacturing plants worldwide.